Description: | Sequence 3 from Patent EP1588718. Therapeutic and preventive agent for allodynia. MEDICAMENT AND METHOD FOR AMELIORATIONG BRAIN FUNCTION. Lymphangiogenesis accelerator. Hepatocyte Growth Factor Gene Therapy to Enhance Musculocutaneous Flap Survival. Lymphangiogenesis accelerator. Sequence 3 from patent US 7790692. | |
Length: | 5181 bp | |
Found in databases: | nrnl1 | |
Found in the following 5 patents: | EP1588718 (lens, espacenet) WO2007013603 (lens, espacenet) JP2005314404 (lens, espacenet) JP2008163007 (lens, espacenet) US7790692 (lens, espacenet) |
View these methods in JRC GMO-Matrix
Event-specific method | |
Element-specific method | |
Construct-specific method | |
Taxon-specific method |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_CS182176 | nrnl1 | Sequence 3 from Patent EP1588718. ... | 5181 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_CS182176 | nrnl1 | Sequence 3 from Patent EP1588718. ... | 5181 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.